North America Drug Discovery Market 2022-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity
- Report ID: 29839
- Date: Jun, 2022
- Pages: 117
- Category: Healthcare & Pharmaceuticals
North America drug discovery market is expected to grow by 7.9% annually in the forecast period and reach $41.44 billion by 2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents.
Highlighted with 27 tables and 60 figures, this 117-page report “North America Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America drug discovery market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America drug discovery market in every aspect of the classification from perspectives of Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Country.
Based on Drug Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Small Molecule Drugs
• Biologic Drugs
Based on Service, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Medicinal Chemical Services
• Biological Services
• Drug Metabolism and Pharmacokinetics (DMPK) Services
• Other Pharmaceutical Services
Based on Process, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Lead Optimization
• Candidate Validation
Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• High Throughput Screening
• Combinatorial Chemistry
• Pharmacogenomics and Pharmacogenetics
• Nanotechnology
• Bioanalytical Instruments
• Biochips
• Bioinformatics
• Other Technologies
Based on Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Oncology
• Neurology
• Infectious and Immune System Diseases
• Digestive System Diseases
• Cardiovascular Diseases
• Diabetes
• Respiratory Disease
• Other Therapeutic Areas
Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Research Institutes
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Drug Type, Service, and Therapeutic Area over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories Inc.
Agilent Technologies Inc.
Astrazeneca plc
Bayer AG
Charles River Laboratories International Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Shimadzu Corp
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of North America Market by Drug Type 43
3.1 Market Overview by Drug Type 43
3.2 Small Molecule Drugs 45
3.3 Biologic Drugs 46
4 Segmentation of North America Market by Service 47
4.1 Market Overview by Service 47
4.2 Medicinal Chemical Services 49
4.3 Biological Services 50
4.4 Drug Metabolism and Pharmacokinetics (DMPK) Services 51
4.5 Other Pharmaceutical Services 52
5 Segmentation of North America Market by Process 53
5.1 Market Overview by Process 53
5.2 Target Selection 55
5.3 Target Validation 56
5.4 Hit-To-Lead Identification 57
5.5 Lead Optimization 58
5.6 Candidate Validation 59
6 Segmentation of North America Market by Technology 60
6.1 Market Overview by Technology 60
6.2 High Throughput Screening 62
6.3 Combinatorial Chemistry 63
6.4 Pharmacogenomics and Pharmacogenetics 64
6.5 Nanotechnology 65
6.6 Bioanalytical Instruments 66
6.7 Biochips 67
6.8 Bioinformatics 68
6.9 Other Technologies 69
7 Segmentation of North America Market by Therapeutic Area 70
7.1 Market Overview by Therapeutic Area 70
7.2 Oncology 72
7.3 Neurology 73
7.4 Infectious and Immune System Diseases 74
7.5 Digestive System Diseases 75
7.6 Cardiovascular Diseases 76
7.7 Diabetes 77
7.8 Respiratory Disease 78
7.9 Other Therapeutic Areas 79
8 Segmentation of North America Market by End User 80
8.1 Market Overview by End User 80
8.2 Pharmaceutical Companies 82
8.3 Contract Research Organizations (CROs) 83
8.4 Research Institutes 84
8.5 Other End Users 85
9 North America Market 2019-2030 by Country 86
9.1 Overview of North America Market 86
9.2 U.S. 89
9.3 Canada 95
9.4 Mexico 97
10 Competitive Landscape 99
10.1 Overview of Key Vendors 99
10.2 New Product Launch, Partnership, Investment, and M&A 102
10.3 Company Profiles 103
Abbott Laboratories Inc. 103
Agilent Technologies Inc. 105
Astrazeneca plc 106
Bayer AG 107
Charles River Laboratories International Inc. 108
Eli Lilly and Company 109
F. Hoffmann-La Roche Ltd 110
GlaxoSmithKline PLC 111
Merck & Co. Inc. 112
Novartis AG 113
Pfizer Inc. 114
Shimadzu Corp 115
Thermo Fisher Scientific Inc. 116
RELATED REPORTS 117
List of Tables
Table 1. Snapshot of North America Drug Discovery Market in Balanced Perspective, 2019-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 21
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 27
Table 4. World Health Spending by Region, $ bn, 2013-2020 30
Table 5. Total Number of Registered Clinical Studies Worldwide, 2010-2019 31
Table 6. Main Product Trends and Market Opportunities in North America Drug Discovery Market 35
Table 7. North America Drug Discovery Market by Drug Type, 2019-2030, $ mn 43
Table 8. North America Drug Discovery Market by Service, 2019-2030, $ mn 47
Table 9. North America Drug Discovery Market by Process, 2019-2030, $ mn 53
Table 10. North America Drug Discovery Market by Technology, 2019-2030, $ mn 60
Table 11. North America Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 70
Table 12. North America Drug Discovery Market by End User, 2019-2030, $ mn 80
Table 13. North America Drug Discovery Market by Country, 2019-2030, $ mn 87
Table 14. U.S. Drug Discovery Market by Drug Type, 2019-2030, $ mn 91
Table 15. U.S. Drug Discovery Market by Service, 2019-2030, $ mn 91
Table 16. U.S. Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 91
Table 17. Novel Drug Approvals in U.S. in 2020 92
Table 18. Canada Drug Discovery Market by Drug Type, 2019-2030, $ mn 96
Table 19. Canada Drug Discovery Market by Service, 2019-2030, $ mn 96
Table 20. Canada Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 96
Table 21. Mexico Drug Discovery Market by Drug Type, 2019-2030, $ mn 98
Table 22. Mexico Drug Discovery Market by Service, 2019-2030, $ mn 98
Table 23. Mexico Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn 98
Table 24. Abbott Laboratories Inc.: Company Snapshot 103
Table 25. Abbott Laboratories Inc.: Business Segmentation 103
Table 26. Abbott Laboratories Inc.: Product Portfolio 104
Table 27. Abbott Laboratories Inc.: Revenue, 2018-2020, $ mn 104
List of Figures
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. North America Drug Discovery Market, 2019-2030, $ mn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of North America Drug Discovery Market 25
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 29
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 29
Figure 9. Primary Restraints and Impact Factors of North America Drug Discovery Market 32
Figure 10. Investment Opportunity Analysis 36
Figure 11. Porter’s Fiver Forces Analysis of North America Drug Discovery Market 39
Figure 12. Breakdown of North America Drug Discovery Market by Drug Type, 2019-2030, % of Revenue 44
Figure 13. North America Addressable Market Cap in 2021-2030 by Drug Type, Value ($ mn) and Share (%) 44
Figure 14. North America Drug Discovery Market by Drug Type: Small Molecule Drugs, 2019-2030, $ mn 45
Figure 15. North America Drug Discovery Market by Drug Type: Biologic Drugs, 2019-2030, $ mn 46
Figure 16. Breakdown of North America Drug Discovery Market by Service, 2019-2030, % of Sales Revenue 48
Figure 17. North America Addressable Market Cap in 2021-2030 by Service, Value ($ mn) and Share (%) 48
Figure 18. North America Drug Discovery Market by Service: Medicinal Chemical Services, 2019-2030, $ mn 49
Figure 19. North America Drug Discovery Market by Service: Biological Services, 2019-2030, $ mn 50
Figure 20. North America Drug Discovery Market by Service: Drug Metabolism and Pharmacokinetics (DMPK) Services, 2019-2030, $ mn 51
Figure 21. North America Drug Discovery Market by Service: Other Pharmaceutical Services, 2019-2030, $ mn 52
Figure 22. Breakdown of North America Drug Discovery Market by Process, 2019-2030, % of Sales Revenue 54
Figure 23. North America Addressable Market Cap in 2021-2030 by Process, Value ($ mn) and Share (%) 54
Figure 24. North America Drug Discovery Market by Process: Target Selection, 2019-2030, $ mn 55
Figure 25. North America Drug Discovery Market by Process: Target Validation, 2019-2030, $ mn 56
Figure 26. North America Drug Discovery Market by Process: Hit-To-Lead Identification, 2019-2030, $ mn 57
Figure 27. North America Drug Discovery Market by Process: Lead Optimization, 2019-2030, $ mn 58
Figure 28. North America Drug Discovery Market by Process: Candidate Validation, 2019-2030, $ mn 59
Figure 29. Breakdown of North America Drug Discovery Market by Technology, 2019-2030, % of Revenue 61
Figure 30. North America Addressable Market Cap in 2021-2030 by Technology, Value ($ mn) and Share (%) 61
Figure 31. North America Drug Discovery Market by Technology: High Throughput Screening, 2019-2030, $ mn 62
Figure 32. North America Drug Discovery Market by Technology: Combinatorial Chemistry, 2019-2030, $ mn 63
Figure 33. North America Drug Discovery Market by Technology: Pharmacogenomics and Pharmacogenetics, 2019-2030, $ mn 64
Figure 34. North America Drug Discovery Market by Technology: Nanotechnology, 2019-2030, $ mn 65
Figure 35. North America Drug Discovery Market by Technology: Bioanalytical Instruments, 2019-2030, $ mn 66
Figure 36. North America Drug Discovery Market by Technology: Biochips, 2019-2030, $ mn 67
Figure 37. North America Drug Discovery Market by Technology: Bioinformatics, 2019-2030, $ mn 68
Figure 38. North America Drug Discovery Market by Technology: Other Technologies, 2019-2030, $ mn 69
Figure 39. Breakdown of North America Drug Discovery Market by Therapeutic Area, 2019-2030, % of Revenue 71
Figure 40. North America Addressable Market Cap in 2021-2030 by Therapeutic Area, Value ($ mn) and Share (%) 71
Figure 41. North America Drug Discovery Market by Therapeutic Area: Oncology, 2019-2030, $ mn 72
Figure 42. North America Drug Discovery Market by Therapeutic Area: Neurology, 2019-2030, $ mn 73
Figure 43. North America Drug Discovery Market by Therapeutic Area: Infectious and Immune System Diseases, 2019-2030, $ mn 74
Figure 44. North America Drug Discovery Market by Therapeutic Area: Digestive System Diseases, 2019-2030, $ mn 75
Figure 45. North America Drug Discovery Market by Therapeutic Area: Cardiovascular Diseases, 2019-2030, $ mn 76
Figure 46. North America Drug Discovery Market by Therapeutic Area: Diabetes, 2019-2030, $ mn 77
Figure 47. North America Drug Discovery Market by Therapeutic Area: Respiratory Disease, 2019-2030, $ mn 78
Figure 48. North America Drug Discovery Market by Therapeutic Area: Other Therapeutic Areas, 2019-2030, $ mn 79
Figure 49. Breakdown of North America Drug Discovery Market by End User, 2019-2030, % of Revenue 80
Figure 50. North America Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 81
Figure 51. North America Drug Discovery Market by End User: Pharmaceutical Companies, 2019-2030, $ mn 82
Figure 52. North America Drug Discovery Market by End User: Contract Research Organizations (CROs), 2019-2030, $ mn 83
Figure 53. North America Drug Discovery Market by End User: Research Institutes, 2019-2030, $ mn 84
Figure 54. North America Drug Discovery Market by End User: Other End Users, 2019-2030, $ mn 85
Figure 55. Breakdown of North America Drug Discovery Market by Country, 2019 and 2030, % of Revenue 87
Figure 56. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%) 88
Figure 57. U.S. Drug Discovery Market, 2019-2030, $ mn 90
Figure 58. Canada Drug Discovery Market, 2019-2030, $ mn 95
Figure 59. Drug Discovery Market in Mexico, 2019-2030, $ mn 97
Figure 60. Growth Stage of North America Drug Discovery Industry over the Forecast Period 99
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
